Zobrazeno 1 - 10
of 71
pro vyhledávání: '"C Calandri"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Franco Baldoni, Gregorio Tugnoli, Andrea Biscardi, Nicola Antonacci, C. Calandri, M. Giovannini, Marco Casali, S. Di Saverio, A. Cancellieri
Publikováno v:
Acta Endoscopica. 40:195-198
Les tumeurs stromales gastro-intestinales (GIST) sont les neoplasies mesenchymateuses les plus frequentes du tube digestif. L’atteinte gastrique est la plus courante (60–70 %), suivie de celle de l’intestin grele (20–30 %). Les GIST possedent
Autor:
Peter C. Harpel, J. B. A. Ross, Elena Rusinova, Jacob H. Rand, Harry A.M. Andree, C. Calandri, Xiao-Xuan Wu, M. G. Gascon-Lema
Publikováno v:
Blood. 92:1652-1660
The antiphospholipid syndrome is a thrombophilic condition marked by antibodies that recognize anionic phospholipid-protein cofactor complexes. We recently reported that exposure to IgG fractions from antiphospholipid patients reduces the level of an
Publikováno v:
British Journal of Dermatology. 145:650-652
We describe a 69-year-old man with a non-small cell carcinoma of the lung, stage III B, who developed bilateral multiple erythematous lesions in the abdominal-inguinal area following treatment with gemcitabine. Histologically, the lesion was characte
Autor:
Daniele Turci, E Ravaioli, Francesco Bonetti, Maria Abbondanza Pantaleo, Corrado Boni, F. Negri, M. C. Marzola, C Banzi, Oriana Nanni, F Di Fabio, I. Carandina, Guido Biasco, S Cataldo, Benedetta Urbini, A Panetta, Alba A. Brandes, G. Lelli, C Calandri
Publikováno v:
Europe PubMed Central
Scopus-Elsevier
Scopus-Elsevier
We carried out a multicentric retrospective study on cetuximab + chemotherapy in pre-treated refractory patients outside clinical protocols, by registering the main clinical and pathological parameters. We evaluated 144 pre-treated patients. Cetuxima
Publikováno v:
Forum (Genoa, Italy). 10(2)
Brain metastases (BrM) are estimated to occur in 20% to 40% of cancer patients, and two-thirds of them become symptomatic during their lifetime. Although every solid tumour may spread to the brain, the risk of developing BrM is higher in lung cancer,
Autor:
J H, Rand, X X, Wu, H A, Andree, J B, Ross, E, Rusinova, M G, Gascon-Lema, C, Calandri, P C, Harpel
Publikováno v:
Blood. 92(5)
The antiphospholipid syndrome is a thrombophilic condition marked by antibodies that recognize anionic phospholipid-protein cofactor complexes. We recently reported that exposure to IgG fractions from antiphospholipid patients reduces the level of an
Autor:
L, Crinò, A M, Mosconi, G V, Scagliotti, G, Selvaggi, M, Rinaldi, M, Della Giulia, C, Gridelli, C, Calandri, F, De Marinis, M, Noseda, M, Tonato
We investigated the activity and toxicity of gemcitabine as a single agent in patients with advanced non-small cell lung cancer (NSCLC) after recurrence or failure of previous treatment with a platinum-containing regimen. From November 1995 to Octobe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::41cb45a86c752613c535d0d0f678a002
http://hdl.handle.net/2318/1691352
http://hdl.handle.net/2318/1691352
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Jacob H. Rand, Seth Guller, Graciela Krikun, Xiao-Xuan Wu, Xiaodong Zhou, Yale Nemerson, Arabinda Guha, C. Calandri, Charles J. Lockwood
Publikováno v:
Placenta. 15(6)
We evaluated the histological and ultrastructural localization of the potent anticoagulant protein, annexin V, at the light and electron microscopic levels, using immunohistochemistry and an immunogold method. Annexin V was found to localize to the m